Wild-type and the Delta F508 mutation of the cystic fibrosis transmembrane
conductance regulator (Delta F508-CFTR) were localised by confocal imaging
in Delta F508/Delta F508 native airway epithelial cells using a well-charac
terised CFTR antibody. Surface nasal epithelial cells from three control an
d three CF individuals were obtained from nasal brushings. Cells were fixed
, permeabilised and incubated with first antibody for 18 h at 4 degreesC. F
ollowing labelling with second antibody, cells were viewed with the confoca
l microscope. Wild-type CFTR was localised predominantly apically, whereas
Delta F508-CFTR was located mainly inside the cell in a region close to the
nucleus. Incubation of cells with MPB-07 (250 muM) at 37 degreesC for 2 h
resulted in pronounced movement of Delta F508-CFTR to the cell periphery, b
ut did not change the localisation of wild-type CFTR. The results show that
Delta F508-CFTR is mislocalised in native nasal epithelial cells and that
its distribution is altered in response to the new CFTR activator, MPB-07 T
he findings should lead to development of a rational drug treatment for CF
patients carrying the Delta F508 mutation.